Cargando…
Blood levels of adiponectin and IL-1Ra distinguish type 3c from type 2 diabetes: Implications for earlier pancreatic cancer detection in new-onset diabetes
BACKGROUND: Screening for pancreatic ductal adenocarcinoma (PDAC) in populations at high risk is recommended. Individuals with new-onset type 2 diabetes mellitus (NOD) are the largest high-risk group for PDAC. To facilitate screening, we sought biomarkers capable of stratifying NOD subjects into tho...
Autores principales: | Oldfield, Lucy, Evans, Anthony, Rao, Rohith Gopala, Jenkinson, Claire, Purewal, Tejpal, Psarelli, Eftychia E., Menon, Usha, Timms, John F., Pereira, Stephen P., Ghaneh, Paula, Greenhalf, William, Halloran, Christopher, Costello, Eithne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8741427/ https://www.ncbi.nlm.nih.gov/pubmed/34990893 http://dx.doi.org/10.1016/j.ebiom.2021.103802 |
Ejemplares similares
-
United Kingdom Early Detection Initiative (UK-EDI): protocol for establishing a national multicentre cohort of individuals with new-onset diabetes for early detection of pancreatic cancer
por: Oldfield, Lucy, et al.
Publicado: (2022) -
The holding temperature of blood during a delay to processing can affect serum and plasma protein measurements
por: Ashworth, Milton, et al.
Publicado: (2021) -
The impact of diabetes mellitus on survival following resection and adjuvant chemotherapy for pancreatic cancer
por: Kleeff, Jörg, et al.
Publicado: (2016) -
Immunobiological effects of gemcitabine and capecitabine combination chemotherapy in advanced pancreatic ductal adenocarcinoma
por: Middleton, Gary, et al.
Publicado: (2016) -
Serum cytokine biomarker panels for discriminating pancreatic cancer from benign pancreatic disease
por: Shaw, Victoria E, et al.
Publicado: (2014)